A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07760454 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07760454
- Sponsor
- UCARsgen Biotech Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2030-12-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.